Turn Therapeutics Inc
turntherapeutics.comWhat Do They Do?
Develops topical drug candidates for inflammatory skin and fungal nail conditions, and licenses wound-care medical devices through commercial partners.
10-K for FY2025, filed Mar 31, 2026Turn Therapeutics is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Our lead program, GX-03…View ↗
In addition to eczema, GX-03 is being advanced for onychomycosis, supported by in-vivo data demonstrating nail penetration and antifungal…View ↗
Our current business model is to license and/or sell medical device products through commercial partners, without significant capital…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Mar 31, 2026
Who Are Their Customers?
Medical-device products are marketed through commercial partners with established sales forces and channels; Medline has a license and supply agreement for K183681. Turn also plans to seek partners for drug programs during approval.
10-K for FY2025, filed Mar 31, 2026For medical device products and indications, we intend to partner with existing organizations with established sales forces and commercial…View ↗
In addition to eczema, GX-03 is being advanced for onychomycosis, supported by in-vivo data demonstrating nail penetration and antifungal…View ↗
Our current business model is to license and/or sell medical device products through commercial partners, without significant capital…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 12, 2026
−$5.8MView ↗
- ▲ +372% (Loss)
- vs −$1.2M in Q2 FY2025
Loading...
